|
Emcure Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
27270.80 Cr.
|
P/BV
|
6.62
|
Book Value (Rs.)
|
217.28
|
|
52 Week High/Low (Rs.)
|
1520/889
|
FV/ML
|
10/1
|
P/E(X)
|
40.03
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.94
|
Div Yield (%)
|
0.21
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 5779.75 |
| Total Income From Operations | 5779.75 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 1123.03 |
| Purchase of Traded Goods | 1311.38 |
| Increase/Decrease in Stocks | -179.91 |
| Employees Cost | 1072.93 |
| Depreciation | 287.29 |
| Other Expenses | 1380.54 |
| Total Expenses | 4995.25 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 784.50 |
| Other Income | 62.99 |
| P/L Before Interest, Excpt. Items & Tax | 847.50 |
| Interest | 136.76 |
| P/L Before Exceptional Items & Tax | 710.74 |
| P/L Before Tax | 710.74 |
| Tax | 200.51 |
| P/L After Tax from Ordinary Activities | 510.23 |
| Net Profit/Loss For the Period | 510.23 |
| Net P/L After Minority Interest & Share Of Associates | 510.23 |
| | |
| Equity Share Capital | 189.43 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | 26.93 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | 26.93 |
| | |
| PBITOE Margin (%) | 13.57 |
| PBTE Margin (%) | 12.29 |
| PBT Margin (%) | 12.29 |
| PAT Margin (%) | 8.82 |
| PAT After MI And SOA Margin (%) | 8.82 |
